Kymanox
58 Case Studies
A Kymanox Case Study
The Client, a pharmaceutical company, faced a significant challenge after its FDA submission for a dry powder inhaler (DPI) device was rejected. The FDA cited major human factors deficiencies in the validation study, including artifacts and poor root cause analysis. The client needed a comprehensive remediation strategy from Kymanox to achieve approval and address usability concerns for its device intended for non-CF bronchiectasis patients.
Kymanox implemented a rigorous human factors engineering solution. This included a complete task and use-error analysis, formative evaluations, and the development of a new training program for specialty pharmacies. Kymanox also successfully executed a remediated validation study with a representative user population. As a result, the client gained critical insight that a device designed for one user group cannot be assumed suitable for another, and Kymanox successfully transformed the client's human factors strategy to be risk-based.
The Client